Insect cell expression and purification of recombinant SARS-COV-2 spike proteins that demonstrate ACE2 binding

7Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 infection has led to socio-economic shutdowns and the loss of over 5 million lives worldwide. There is a need for the identification of therapeutic targets to treat COVID-19. SARS-CoV-2 spike is a target of interest for the development of therapeutic targets. We developed a robust SARS-CoV-2 S spike expression and purification protocol from insect cells and studied four recombinant SARS-CoV-2 spike protein constructs based on the original SARS-CoV-2 sequence using a baculovirus expression system: a spike protein receptor-binding domain that includes the SD1 domain (RBD) coupled to a fluorescent tag (S-RBD-eGFP), spike ectodomain coupled to a fluorescent tag (S-Ecto-eGFP), spike ectodomain with six proline mutations and a foldon domain (S-Ecto-HexaPro(+F)), and spike ectodomain with six proline mutations without the foldon domain (S-Ecto-HexaPro(-F)). We tested the yield of purified protein expressed from the insect cell lines Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tni) and compared it to previous research using mammalian cell lines to determine changes in protein yield. We demonstrated quick and inexpensive production of functional glycosylated spike protein of high purity capable of recognizing and binding to the angiotensin converting enzyme 2 (ACE2) receptor. To further confirm functionality, we demonstrate binding of eGFP fused construct of the spike ectodomain (S-Ecto-eGFP) to surface ACE2 receptors on lung epithelial cells by flow cytometry analysis and show that it can be decreased by means of receptor manipulation (blockade or downregulation).

References Powered by Scopus

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

6378Citations
N/AReaders
Get full text

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

6288Citations
N/AReaders
Get full text

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

4354Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigens

17Citations
N/AReaders
Get full text

Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

1Citations
N/AReaders
Get full text

The Glycan Ectodomain of SARS-CoV-2 Spike Protein Modulates Cytokine Production and Expression of CD206 Mannose Receptor in PBMC Cultures of Pre-COVID-19 Healthy Subjects

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Struble, L. R., Smith, A. L., Lutz, W. E., Grubbs, G., Sagar, S., Bayles, K. W., … Borgstahl, G. E. O. (2022). Insect cell expression and purification of recombinant SARS-COV-2 spike proteins that demonstrate ACE2 binding. Protein Science, 31(5). https://doi.org/10.1002/pro.4300

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

57%

Researcher 6

43%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

60%

Agricultural and Biological Sciences 2

13%

Medicine and Dentistry 2

13%

Immunology and Microbiology 2

13%

Save time finding and organizing research with Mendeley

Sign up for free